Chikungunya by PCR
Also known as: CHIKPCR
Use
This test is used to detect chikungunya virus through qualitative Polymerase Chain Reaction (PCR) methodology. It is especially useful for diagnostic purposes in clinical settings, allowing for the identification of chikungunya infection. By detecting the presence of chikungunya virus nucleic acid in serum or plasma samples, this test serves as a crucial tool for timely diagnosis and management of the disease, particularly in regions affected by mosquito-borne arboviruses.
Special Instructions
Specimen source is required when submitting samples for testing. The test is performed on specific collection days, which are Tuesday and Friday, and laboratory reports are typically available in 2 to 5 days post collection. It is important to handle specimens according to the storage instructions to ensure their viability.
Limitations
The test has not been cleared or approved by the US Food and Drug Administration (FDA) but has been developed and its performance characteristics determined by ARUP Laboratories. It is performed under a CLIA certified laboratory designation and meant solely for clinical purposes. A negative result does not rule out the presence of PCR inhibitors in the specimen or nucleic acid present in concentrations below the assay's detection capability. Additionally, heparinized specimens are not suitable for this test and will be rejected.
New York Approved
Methodology
PCR-based (Qualitative Polymerase Chain Reaction)
Biomarkers
LOINC Codes
- 31208-2
- 60260-7
Result Turnaround Time
2-5 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
1 mL
Minimum Volume
0.5 mL
Container
Sterile container
Collection Instructions
Separate serum or plasma from cells before transfer.
Storage Instructions
Store the sample frozen.
Causes for Rejection
Heparinized specimens are unacceptable.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 5 days |
| Frozen | 6 months |